Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Grant
Adjust height of sidebar
KMap
Grant
A Dose Escalation and Expansion Study of the Safety and Pharmacokinetics of XL114 in Subjects with Non-Hodgkins Lymphoma
Sponsored by Exelixis Pharmaceuticals, Incorporated
Active
$236.5K Funding
5 People
External
Related Topics
pharmacokinetics,
oncology,
clinical trial,
safety,
dose escalation
People
Lora Inclan
(CD)
Cancer Center Division
﹒Clinical Research Coordinator III
Patricia Robles Quihuis
(CD)
Cancer Center Division
﹒Research Nurse III
Carolyn Lane
(CD)
Cancer Center Division
﹒Research Laboratory Manager I
Michele Chu-Pilli
(CD)
Cancer Center Division
﹒Research Program Administration Officer III
Brianna Denton
(CD)
Cancer Center Division
﹒Research Compliance Manager I
